BaseSpace
Correlation
Engine-Public
Sign In
Register
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
Diabetes mellitus
,
Endothelial cell
,
Anticancer prodrugs
,
Rapamycin
,
rs2300478
,
MYC
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
RRM2
(gene)
Summary
General Info
Body Atlas
Most Correlated Tissues
Plasma cell of spleen
Fetal liver
Granulocyte-macrophage progenitor cell of bone marrow
Thymus gland
Hematopoietic stem cell of bone marrow
Explore Body Atlas Results
Disease Atlas
Most Correlated Diseases
Injury of liver
Liver regeneration
T-cell lymphoma
Vesicular stomatitis Indiana virus disease
Social environment related disease
Explore Disease Atlas Results
Pharmaco Atlas
Most Correlated Compounds
lodenosine
cyclopropane
Salicylic Acid
Epstein-Barr Virus Nuclear Antigens
Disopyramide
Explore Pharmaco Atlas Results
Knockdown Atlas
Most Correlated Gene Perturbations
CLOCK
ONECUT2
LMO1
ACVR1
DDX6
Explore Knockdown Atlas Results
Curated Studies
Most Correlated Studies
Loading...
Explore Curated Studies Results
Literature
Most Relevant Literature
Serum ribonucleotide reductase M2 is a potential biomarker for diagnosing and monitoring liver fibro…
IKBKE regulates renal cell carcinoma progression and sunitinib resistance through the RRM2-AKT pathw…
The High Expression of RRM2 Can Predict the Malignant Transformation of Endometriosis.
Overexpression of RRM2 is related to poor prognosis in oral squamous cell carcinoma.
RRM2 Improves Cardiomyocyte Proliferation after Myocardial Ischemia Reperfusion Injury through the H…
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
RNR Inhibitor COH29 in Treating Patients With Solid Tumors That Are Refractory to Standard Therapy o…
A Phase II Trial of Triapine (NSC #663249) in Combination With Gemcitabine as Second Line Treatment …
GTI-2040 in Treating Patients With Relapsed, Refractory, or High-Risk Acute Leukemia, High-Grade Mye…
Phase 0 Study of Metronomic Oral Vinorelbine and Letrozole in HR+/HER2-negative Early Breast Cancer …
Acelarin First Line Randomised Pancreatic Study
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ